San Diego, CA – According to filings with the U.S. Securities and Exchange Commission, Histogen is raising $30,000,000.00 in a new round of investment. Sources indicate as part of senior management Chief Executive Officer, Richard Pascoe played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Histogen

Histogen is a regenerative medicine company with a unique biological platform that replaces and regenerates tissues in the body. This innovative technology utilizes human proteins and growth factors produced by hypoxia-induced multipotent cells to address underserved, multibillion dollar global markets.

To learn more about Histogen, visit http://www.histogen.com/

Contact:
Richard Pascoe, Chief Executive Officer
858-526-3100
rpascoe@histogen.com
https://www.linkedin.com/in/rpascoe/

SOURCE: http://www.intelligence360.io
Copyright (c) 2019 SI360 Inc. All rights reserved